China restricts investigator-initiated biotech clinical trials after patient deaths
The crackdown leaves rare disease families and US investors facing uncertainty as a once-booming pipeline of trials slows.
Read at STAT →Full coverage · 7 outlets
- STAT · lead
- The Straits TimesPatient death in China gene-editing trial draws fire: Journal
- Fierce BiotechAfter 2 undisclosed gene therapy deaths, can China’s alternative regulatory path still be trusted?
- Endpoints NewsThree deaths in China shake trust in the country's speedy clinical trial system
- Bloomberg.comChild Died in Chinese Biotech Firm’s Gene Editing Trial
- Tech TimesHuidaGene Hid Boy’s Gene Therapy Death for 12 Months: China Trial System Failed
- NatureChina’s fast-track clinical trials are in the spotlight after child deaths